Skip to main content

Table 1 Characteristics of studies included for meta-analysis

From: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis

First author

Year

Duration (months)

Histology

Stage

Patient number

Quality score

Detection

Platform

Yuan A [40]

2000

28

NSCLC

I–III

58

8

Microarray

Perkin-Elmer Applied Biosystems

Tang H [41]

2013

120

NSCLC

I–III

176

9

Microarray

IlluminaHumanWG-6v3.0

Raponi M [42]

2006

144

SQC

I–III

129

8

Microarray

AffymetrixHgu133plus2.0

Tomida S [43]

2009

109.8

ADC

I–III

117

9

Microarray

AgilentWholeHumanGenomeMicroarray 4x44K G4112F

Botling J [44]

2013

120

NSCLC

I–IV

196

8

Microarray

AffymetrixHgu133plus2.0

Beer DG [45]

2002

110.6

ADC

I–III

86

8

Microarray

AffymetrixHumanFullLength HuGeneFL

Landi MT [46]

2008

NR

ADC

I–IV

74

9

Microarray

AffymetrixHgu133a

Lu T [47]

2010

NR

ADC

I–IV

60

8

Microarray

AffymetrixHgu133plus2.0

Selamat SA [48]

2012

NR

ADC

I–III

58

8

Microarray

IlluminaHumanWG-6v3.0 expression

Meyerson M [49]

2015

NR

SQC

I–IV

135

8

Microarray

AffymetrixHgu133a

  1. Cutoff value: median expression
  2. NR not reporting, ADC lung adenocarcinoma, SQC lung squamous cell carcinoma